Inventor · disambiguated record
Han Chang
Also filed as: CHANG HAN · CHANG HAN-CHIH · LEE LIANA M
32 granted patents·15 pending applications·499 citations·filing 2001–2025
97Inventor score
Files withBRISTOL MYERS SQUIBB CO41LI MING HSIN2MIKESELL GLEN EUGENE2CHANG SHIH HO1INER ATOMIC ENERGY COUNCIL EXECUTIVE YUAN1
Top patents by PatentIndex Score
47 records- 0197US7358354B2Polynucleotides encoding BSL3BRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 15, 2008·75 cites·24 claims
- 0297US6965018B2Antibodies directed to B7-related polypeptide, BSL-2BRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 15, 2005·135 cites·28 claims
- 0396US7368554B2Polynucleotides encoding BSL2v1c2-IgBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 6, 2008·53 cites·11 claims
- 0496US7279567B2Polynucleotides-encoding B7-related polypeptide, BSL2-L165-35BBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 9, 2007·77 cites·16 claims
- 0595US9644032B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 9, 2017·12 cites·30 claims
- 0695US7723479B2BSL3 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 25, 2010·36 cites·16 claims
- 0794US9603950B1Compounds of imaging agent with HDAC inhibitor for treatment of Alzheimer syndrome and method of synthesis thereofLI MING-HSIN·Filed 2015·Granted Mar 28, 2017·21 cites·3 claims
- 0893US8354513B2Polynucleotides encoding BSL2vcvc-lgBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 15, 2013·10 cites·16 claims
- 0992US9409970B2Polynucleotides encoding BSL2v2c2BRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 9, 2016·14 cites·5 claims
- 1090US11919957B2Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 5, 2024·4 cites·13 claims
- 1188US7807786B2BSL2v1c2 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Oct 5, 2010·5 cites·13 claims
- 1288US7223557B2Polynucleotide encoding a TRP channel family member, TRP-PLIK2BRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 29, 2007·18 cites·21 claims
- 1387US12466888B2Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Nov 11, 2025·1 cites·19 claims
- 1487US8674076B2BSL2vcvc-lg polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Mar 18, 2014·3 cites·14 claims
- 1585US8080636B2BSL3 antibodiesMIKESELL GLEN EUGENE·Filed 2010·Granted Dec 20, 2011·7 cites·24 claims
- 1685US7056737B2Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, HGRA4, and splice variant thereofBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jun 6, 2006·21 cites·6 claims
- 1783US11466092B2Antibodies against OX-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·19 claims
- 1881US10683357B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 16, 2020·1 cites·19 claims
- 1980US8664360B2BSL3 polypeptidesMIKESELL GLEN EUGENE·Filed 2011·Granted Mar 4, 2014·3 cites·4 claims
- 2078US2023272100A1Antibodies against ox-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2176US2025382368A1Methods of treating a non-small cell lung cancer using an anti-pd-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 2274US10590183B2BSL2v2c2-Ig polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 17, 2020·0 cites·2 claims
- 2373US2025059610A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2473US2020369744A1BSL2v2c2-Ig POLYPEPTIDESBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2571US7101686B1Polynucleotides encoding human SLAP-2:a novel SH2/SH3 domain-containing human SLAP homologue having immune cell-specific expressionBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 5, 2006·2 cites·13 claims
- 2670US2022315657A1Anti-pd-1 antibody for use in a method of treating a tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2769US9399052B2Polynucleotides encoding BSL2v2c2-IgBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 26, 2016·0 cites·25 claims
- 2869US2020079835A1B7-related nucleic acids and polypeptides useful for immunomodulationBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2967US2023295737A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3066US10308702B2BSL2v2c2-Ig polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 4, 2019·0 cites·19 claims
- 3165US2024190963A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3264US10400023B2B7-related nucleic acids and polypeptides useful for immunomodulationBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·0 cites·17 claims
- 3363US2025340645A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3462US7667003B2Antibody directed to human mist (mast cell immunoreceptor signal transducer)BRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 23, 2010·0 cites·25 claims
- 3560US7541434B2Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variantsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 2, 2009·0 cites·13 claims
- 3659US2020239577A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3758US7442770B2Human clnk-related polypeptide, MIST (Mast Cell Immunoreceptor Signal Transducer)BRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 28, 2008·0 cites·19 claims
- 3857US7241590B2Identification and cloning of a full-length human Clnk-related gene, MIST (mast cell immunoreceptor signal transducer)BRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 10, 2007·0 cites·34 claims
- 3956US2020325226A1Anti-pd-1 antibody for use in a method of treating a tumorBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4054US7517957B2Human SLAP-2: a novel SH2/ SH3 domain-containing human SLAP homologue having immune cell-specific expressionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 14, 2009·0 cites·9 claims
- 4154US2022041733A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 4252US11697993B1Rotary engineCHANG SHIH HO·Filed 2022·Granted Jul 11, 2023·0 cites·16 claims
- 4351US2021101980A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 4450US10005727B2Compound and analogues for tracing histone acetylation inhibitors PET imaging for diagnosis and treatment of tumorsLI MING HSIN·Filed 2016·Granted Jun 26, 2018·0 cites·7 claims
- 4547US2022195046A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 4644US2021032344A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 4730US10507250B2Precursor of a histone deacetylase inhibitor PET imaging compound for tracking cerebral neurodegenerative and tumor diseasesINER ATOMIC ENERGY COUNCIL EXECUTIVE YUAN·Filed 2017·Granted Dec 17, 2019·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →